Avadel Pharma (AVDL) Reports Q4 Loss of $0.46/Share

Avadel Pharma (NASDAQ: AVDL) reported Q4 EPS of ($0.46), versus ($0.25) reported last year. Revenue for the quarter came in at $20.9 million, versus $34.75 million reported last year.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• L3Harris CEO steps down amid conduct review, shares drop